Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PER2 | O15055 | 1/20 | 0.31 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.31 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | PDE6D | O43924 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24374024 | 0.96 | KDM4E (0.36) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL24374278 | 0.96 | KDM4E (0.36) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL20009818 | 0.94 | L3MBTL1 (0.37) | KDM4EATML3MBTL1HDAC4PDE6D | |
| SCHEMBL20812940 | 0.94 | L3MBTL1 (0.37) | KDM4EATML3MBTL1HDAC4PDE6D | |
| SCHEMBL24374251 | 0.93 | KDM4E (0.35) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL24949615 | 0.93 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4PDE6D | |
| SCHEMBL20009830 | 0.93 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4PDE6D | |
| SCHEMBL15138069 | 0.93 | KDM4E (0.36) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL24948574 | 0.93 | KDM4E (0.31) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL26165988 | 0.93 | CA12 (0.31) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10573824-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. (KR) | 2020-02-25 | — | — | US | disclosed |
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, BMI1 | KDM4E 390/4885ATM 2315/4885L3MBTL1 1563/4885 |
| US-10573824-B2 | Compound and organic electronic element comprising same | OR10J3, ETV6, BMI1 | KDM4E 390/4885ATM 2315/4885L3MBTL1 1563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.